UPDATE : Monday, September 7, 2020
상단여백
Medical supplies trade with China turn to black in 2017
Korea’s exports of medical and pharmaceutical products to China increased t...
by Nam Doo-hyun  |  2017-12-04 16:09
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
라인
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun  |  2017-12-01 11:48
라인
Sexual scandal at Pfizer Korea belatedly uncovered 
After hospitals came under fire for senior physicians’ sexual violence agai...
by Nam Doo-hyun  |  2017-11-30 16:29
라인
Nanomedicine market to grow rapidly: report
With researchers actively using nanotechnology to treat diseases, the nanom...
by Nam Doo-hyun  |  2017-11-29 16:47
라인
‘Weak digital healthcare sector might be eaten by foreign capital’
“Multinational companies are leading the local digital healthcare industry....
by Nam Doo-hyun  |  2017-11-29 14:39
라인
Hospital wins patent in VR treatment for cognitive disorders
A local hospital is drawing attention by winning a patent in cognitive reha...
by Nam Doo-hyun  |  2017-11-27 16:05
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun  |  2017-11-27 13:13
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun  |  2017-11-24 15:53
라인
Zuellig Pharma Korea CEO treats workers like ‘dogs and pigs’: union
The labor union of Zuellig Pharma Korea has launched a series of one-man pr...
by Nam Doo-hyun  |  2017-11-21 13:43
라인
‘Pharmaceuticals’ main mission is R&D, not marketing’
One can find quite a few people working not just in multinational pharmaceu...
by Nam Doo-hyun  |  2017-11-20 16:37
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
ViroMed said it would conduct a phase 1 clinical trial on CAR-T (chimeric a...
by Nam Doo-hyun  |  2017-11-17 13:53
라인
Earthquake hits biopharmaceutical factories in Pohang
With a magnitude 5.4 quake hitting Pohang in North Gyeongsang Province, ind...
by Nam Doo-hyun  |  2017-11-16 15:55
라인
New US guideline adds 6.5 million to Korean hypertension patients
As the American Heart Association and the American College of Cardiology re...
by Nam Doo-hyun  |  2017-11-16 14:38
라인
InBody stocks rise on record Q3 earnings
The share prices of InBody, a manufacturer of body composition analyzers, a...
by Nam Doo-hyun  |  2017-11-14 15:49
라인
Do adverse effects of statin increase if more people know about them?
A research result about the “nocebo effect” of statin, the base material fo...
by Nam Doo-hyun  |  2017-11-14 06:30
라인
Biopharmaceutical firms rank high in Kosdaq market cap
Biopharmaceutical firms are showing strong performance on South Korea’s tec...
by Nam Doo-hyun  |  2017-11-13 15:25
라인
Big-3 companies take up half of healthcare market cap
Combined market capitalization of Celltrion Group, Samsung BioLogics and Ha...
by Nam Doo-hyun  |  2017-11-09 11:21
라인
Daewoong salespersons unhappy about management system
Daewoong Pharmaceutical is known for its strong marketing ability among loc...
by Nam Doo-hyun  |  2017-11-08 16:48
라인
ViroMed, Reyon in legal battle over gene therapy patent rights
The exclusive contract between ViroMed and Reyon Pharmaceutical to jointly ...
by Nam Doo-hyun  |  2017-11-07 14:10
여백
여백
여백
Back to Top